Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
BRTX
|
Dale Broadrick |
BUY
Open market or private purchase
|
Direct | 10,000 Added 4.63% |
$43,500
$4.35 p/Share
|
Mar 21
2022 |
|
PQEFF
|
Anthony J Cantone
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 563,063 Added 0.73% |
$191,441
$0.34 p/Share
|
Mar 21
2022 |
|
FUSN
|
John Valliant
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 700 Reduced 0.19% |
$5,222
$7.46 p/Share
|
Mar 21
2022 |
|
SKAS
|
Roy Moskowitz
Director |
SELL
Open market or private sale
|
Direct | 1,300 Reduced 18.25% |
$5,148
$3.96 p/Share
|
Mar 21
2022 |
|
HOFV
|
Benjamin J Lee
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 612,369 Added 50.0% |
-
|
Mar 21
2022 |
|
NVST
|
Patrik Eriksson
Senior Vice President |
BUY
Discretionary transaction
|
Indirect | 4,005 Added 50.0% |
$189,276
$47.26 p/Share
|
Mar 21
2022 |
|
CLR
|
Mark E Monroe
Director |
SELL
Bona fide gift
|
Direct | 5,000 Reduced 2.02% |
-
|
Mar 21
2022 |
|
ADSK
|
Pascal W Di Fronzo
EVP, Corp Affairs, CLO |
SELL
Payment of exercise price or tax liability
|
Direct | 4,238 Reduced 25.92% |
$942,107
$222.3 p/Share
|
Mar 21
2022 |
|
ADSK
|
Pascal W Di Fronzo
EVP, Corp Affairs, CLO |
BUY
Grant, award, or other acquisition
|
Direct | 5,916 Added 26.57% |
-
|
Mar 21
2022 |
|
ADSK
|
Andrew Anagnost
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 24,021 Reduced 24.68% |
$5,123,679
$213.3 p/Share
|
Mar 21
2022 |
|
ADSK
|
Andrew Anagnost
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 29,844 Added 23.47% |
-
|
Mar 21
2022 |
|
ADSK
|
Steven M Blum
EVP, Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Indirect | 9,989 Added 23.26% |
-
|
Mar 21
2022 |
|
ADSK
|
Steven M Blum
EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,587 Reduced 10.45% |
$551,807
$213.3 p/Share
|
Mar 21
2022 |
|
ADSK
|
Steven M Blum
EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Indirect | 3,479 Reduced 10.56% |
$742,071
$213.3 p/Share
|
Mar 21
2022 |
|
ADSK
|
Stephen W. Hope
SVP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 625 Reduced 13.5% |
$133,313
$213.3 p/Share
|
Mar 21
2022 |
|
ADSK
|
Stephen W. Hope
SVP & Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 875 Added 15.89% |
-
|
Mar 21
2022 |
|
NBXG
|
Martha Clark Goss |
SELL
Open market or private sale
|
Direct | 1,250 Reduced 100.0% |
$16,850
$13.48 p/Share
|
Mar 21
2022 |
|
FRGE
|
Motive Capital Funds Sponsor, LLC |
BUY
Exercise of conversion of derivative security
|
Direct | 10,230,000 Added 50.0% |
-
|
Mar 21
2022 |
|
FRGE
|
Paul Luc Robert Heyvaert
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 14,000,000 Added 36.62% |
-
|
Mar 21
2022 |
|
FRGE
|
Paul Luc Robert Heyvaert
> 10% Shareholder |
BUY
Exercise of conversion of derivative security
|
Indirect | 10,230,000 Added 50.0% |
-
|
Mar 21
2022 |
|
FRGE
|
Jill M Considine |
BUY
Exercise of conversion of derivative security
|
Direct | 30,000 Added 50.0% |
-
|
Mar 21
2022 |
|
FRGE
|
Paula Madoff |
BUY
Exercise of conversion of derivative security
|
Direct | 30,000 Added 50.0% |
-
|
Mar 21
2022 |
|
FRGE
|
Dina Dublon |
BUY
Exercise of conversion of derivative security
|
Direct | 30,000 Added 50.0% |
-
|
Mar 21
2022 |
|
FRGE
|
Stephen C. Daffron |
BUY
Exercise of conversion of derivative security
|
Direct | 30,000 Added 50.0% |
-
|
Mar 21
2022 |
|
HCYTD
|
Frederick J Lynch
> 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect | 8,321,785 Added 50.0% |
$83,218
$0.01 p/Share
|
Mar 21
2022 |
|
TISI
|
Evan S. Lederman
Director |
BUY
Open market or private purchase
|
Direct | 3,500 Added 50.0% |
$5,705
$1.63 p/Share
|
Mar 21
2022 |
|
APLT
|
Riccardo Perfetti
Chief Medical Officer |
BUY
Open market or private purchase
|
Direct | 12,548 Added 10.33% |
$23,214
$1.85 p/Share
|
Mar 21
2022 |
|
CDTX
|
Brady Johnson
Vice President, Finance |
SELL
Open market or private sale
|
Direct | 654 Reduced 1.31% |
$530
$0.81 p/Share
|
Mar 21
2022 |
|
WLMS
|
David A B Brown
Director |
BUY
Open market or private purchase
|
Direct | 41,737 Added 7.83% |
$72,205
$1.73 p/Share
|
Mar 21
2022 |
|
WLMS
|
Raymond A. Hruby Jr.
EVP, Business Development |
BUY
Open market or private purchase
|
Direct | 18,000 Added 47.37% |
$31,500
$1.75 p/Share
|
Mar 21
2022 |
|
WLMS
|
Mitchell I Quain
Director |
BUY
Open market or private purchase
|
Direct | 10,000 Added 9.4% |
$16,500
$1.65 p/Share
|
Mar 21
2022 |
|
TCON
|
Charles Theuer
PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Direct | 1,200 Added 0.54% |
$2,940
$2.45 p/Share
|
Mar 21
2022 |
|
AUID
|
Thomas L Thimot
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect | 27,027 Added 21.54% |
$100,000
$3.7 p/Share
|
Mar 21
2022 |
|
AUID
|
Michael A Gorriz |
BUY
Grant, award, or other acquisition
|
Direct | 311 Added 50.0% |
$1,001
$3.22 p/Share
|
Mar 21
2022 |
|
AUID
|
Philip R Broenniman
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 3,106 Added 0.9% |
$10,001
$3.22 p/Share
|
Mar 21
2022 |
|
AUID
|
Philip R Broenniman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 311 Added 0.18% |
$1,001
$3.22 p/Share
|
Mar 21
2022 |
|
AUID
|
Phillip L Kumnick
Director |
BUY
Grant, award, or other acquisition
|
Direct | 13,514 Added 9.1% |
$50,002
$3.7 p/Share
|
Mar 21
2022 |
|
AUID
|
Stuart Stoller
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 155 Added 0.19% |
$499
$3.22 p/Share
|
Mar 21
2022 |
|
KIRK
|
Ann E Joyce |
BUY
Open market or private purchase
|
Direct | 2,242 Added 29.59% |
$24,976
$11.14 p/Share
|
Mar 21
2022 |
|
HGBL
|
Samuel L Shimer |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 6.06% |
$4,200
$0.42 p/Share
|
Mar 21
2022 |
|
RAIL
|
Michael Anthony Riordan
VP Finance, CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct | 40,000 Added 36.95% |
-
|
Mar 21
2022 |
|
JSPR
|
William Lis
Director |
BUY
Grant, award, or other acquisition
|
Direct | 89,972 Added 50.0% |
-
|
Mar 21
2022 |
|
FTK
|
David Nierenberg
Director |
BUY
Conversion of derivative security
|
Indirect | 2,793,030 Added 26.17% |
-
|
Mar 21
2022 |
|
RDI
|
Ellen M Cotter
Director, President and CEO |
SELL
Open market or private sale
|
Indirect | 2,750 Reduced 0.21% |
$12,210
$4.44 p/Share
|
Mar 21
2022 |
|
RDI
|
James J. Cotter Living Trust
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 2,750 Reduced 0.21% |
$12,210
$4.44 p/Share
|
Mar 21
2022 |
|
RDI
|
Margaret Cotter
Chairperson, EVP - RE Dev/NY |
SELL
Open market or private sale
|
Indirect | 2,750 Reduced 0.21% |
$12,210
$4.44 p/Share
|
Mar 21
2022 |
|
RRGB
|
Michael Buchmeier
CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 7,029 Added 21.6% |
-
|
Mar 21
2022 |
|
RRGB
|
Geoffrey Wayne Davis
CHIEF PEOPLE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 7,988 Added 32.99% |
-
|
Mar 21
2022 |
|
RRGB
|
Darla Morse
CHIEF INFORMATION OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 8,901 Added 34.83% |
-
|
Mar 21
2022 |
|
RRGB
|
Michael L. Kaplan
CHIEF LEGAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 14,418 Added 28.27% |
-
|
Mar 21
2022 |